Literature DB >> 23786586

Vascular endothelial growth factor and physiological compressive loading synergistically promote bone formation of tissue-engineered bone.

Xuehui Wu1, Tianyong Hou, Fei Luo, Junchao Xing, Qingyi He, Huiyong Jin, Zhao Xie, Jianzhong Xu.   

Abstract

Angiogenesis and osteogenesis are essential for healing bone injuries, especially those related to critically sized bone defect (CSBD). Bone tissue engineering is a promising method for repairing bone defect, but the inherently poor nutrient supply and the slow osteogenesis of large size defect are two obstacles. This leads to an urgent need to understand how to orchestrate angiogenesis and osteogenesis for promoting bone defect healing. In this article, poly-L-lysine-coated vascular endothelial growth factor/alginate controlled releasing microspheres (VEGF-AG-PLL) were fabricated in tissue-engineered bone (TEB), and then the composite was implanted into the CSBD of goat femurs. Dynamic intramedullary rod was utilized to fixate the femur and produce an analogous physiological axial compression. We found that VEGF released in early stage not only promoted angiogenesis, but also brought benefit to osteogenesis. Meanwhile, in early stage physiological axial compression could regulate angiogenesis and facilitate VEGF release from the composite. In later stage, compression could accelerate reconstruction of TEB. In conclusion, this study demonstrated that the collaborative application of VEGF and compression could accelerate the reconstruction of TEB; thus, providing a new strategy for clinically repairing large bone defect in future.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23786586     DOI: 10.1089/ten.TEA.2013.0124

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  2 in total

1.  Pituitary adenylate cyclase-activating polypeptide (PACAP) signalling enhances osteogenesis in UMR-106 cell line.

Authors:  Tamás Juhász; Csaba Matta; Éva Katona; Csilla Somogyi; Roland Takács; Tibor Hajdú; Solveig Lind Helgadottir; János Fodor; László Csernoch; Gábor Tóth; Éva Bakó; Dóra Reglődi; Andrea Tamás; Róza Zákány
Journal:  J Mol Neurosci       Date:  2014-08-12       Impact factor: 3.444

2.  Improved osteogenic differentiation of umbilical cord blood MSCs using custom made perfusion bioreactor.

Authors:  Bhaskar Birru; Naveen Kumar Mekala; Sreenivasa Rao Parcha
Journal:  Biomed J       Date:  2018-11-16       Impact factor: 4.910

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.